[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus]. [electronic resource]
Producer: 20110120Description: 618-25 p. digitalISSN:- 0211-6995
- Absorption
- Animals
- Benzhydryl Compounds
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Dogs
- Double-Blind Method
- Gluconeogenesis -- drug effects
- Glucose -- metabolism
- Glucosides -- adverse effects
- Glycosuria, Renal -- drug therapy
- Homeostasis
- Humans
- Hypoglycemic Agents -- pharmacology
- Kidney -- metabolism
- Kidney Tubules, Proximal -- metabolism
- Mice
- Phlorhizin -- adverse effects
- Randomized Controlled Trials as Topic
- Sodium-Glucose Transporter 1 -- physiology
- Sodium-Glucose Transporter 2 -- genetics
- Sodium-Glucose Transporter 2 Inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.